Background—
Reducing digital pulse rates (PR) are known to reduce total energy during invasive cardiovascular procedures, which likely has benefits for patients and staff. Physicians may be reluctant to reduce these parameters because they fear a decline in image quality that could affect procedural outcomes. We sought to assess the effect of default rates of fluoroscopy (Fluoro) and CINE-acquisition (CINE) on total x-ray dose and image quality during invasive cardiovascular procedures.
Methods and Results—
We retrospectively reviewed procedures done with 2 default PRs: a standard dose cohort (PR, 15 for Fluoro and CINE), and a reduced dose cohort (PR, 10 for Fluoro and CINE). Total x-ray dose, Fluoro time, and contrast use were compared between groups. A blinded angiographic image quality assessment was then performed using an objective 10-point angiographic quality score. There were no significant differences between cohorts for fluoroscopy time or contrast use. The reduced dose cohort has a significant reduction in mean total x-ray dose (PR 15, 1763.1 mGy; PR 10, 1179.1 mGy;
P
<0.0001). When adjusted for potential confounders, a 38% reduction in total x-ray dose was identified (
P
<0.0001). There was no difference in adjusted angiographic quality score between the cohorts (PR 15, 7.90; PR 10, 8.00;
P
=0.67), indicating no decline in image quality with PR reduction.
Conclusions—
Reducing default PRs during invasive cardiovascular procedures yields large and significant reductions in total x-ray energy with no decline in angiographic image quality.
Urgent and timely revascularization is a wellestablished cornerstone of therapy in the treatment of ST elevation myocardial infarction (STEMI). However, guidelines directing therapy in non-ST segment elevation myocardial infarction (NSTEMI) are not as definitive. These guidelines recommend two treatment pathways: an early invasive strategy (EIS) and an initial conservative strategy.The EIS directs patients toward invasive diagnostic evaluation often prior to noninvasive testing, without failing medical therapy, and on a more expeditious time frame (<24 h from presentation). This strategy confers several advantages besides risk stratification alone. Percutaneous intervention of the culprit lesion reduces the need for chronic anti-anginal therapy and rehospitalizations. In addition, patients identified as having multivessel disease would gain the added mortality benefit from referral for coronary artery bypass graft surgery early.The initial conservative strategy recommends an invasive approach for those who fail medical therapy or if there is objective evidence of active ischemia on noninvasive testing. This strategy has the advantage of avoiding the risks associated with an invasive procedure. When this strategy is chosen, often noninvasive evaluation is required to assess for significant ischemia and to identify left ventricular dysfunction. Deciding which strategy to take can be done based on riskstratifying patients using risk calculators such as thrombolysis in myocardial infarction (MI) or the global registry of acute coronary events calculator [1].In the United States, among people who died of ischemic heart disease, 83% were older than 65 years. Moreover, even though people older than 75 years only account for 6% of the US population, they represent 60% of MI-related deaths [2]. Increasing age is one of the major predictors of poorer outcomes in NSTEMI. However, despite the fact that the guidelines recommend therapeutic interventions based on risk rather than age, there appears to be widespread reluctance to use an invasive strategy in a uniform manner in the elderly population. This is likely in part, due to the fact that the elderly population is under-represented or excluded in acute coronary syndrome (ACS) clinical trials; therefore, there is limited evidence guiding treatment in this population.In this issue of Catheterization and Cardiovascular Interventions, Angeli et al.[3] present a meta-analysis of nine randomized clinical trials (RCTs) involving 9,400 patients comparing the benefit of an EIS to a selectively invasive strategy (SIS). The primary composite endpoint of MI and all-cause death was 16% in the EIS group and 18.3% in the SIS group (OR: 0.85, 95% CI: 0.76-0.95). In addition, the reduction in rehospitalization and recurrent MI was greater in the older population (>65 years) as compared to younger study populations. Moreover, the benefit was seen in both male and female subgroups.This article adds to the evidence suggesting the benefits of EIS that has been accumulating since 1999. Evidenc...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.